- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04960410
Real Time Early Warning Model and Mobile Medical Assistant System for the Impact of Air Pollution on AECOPD Disease
July 4, 2021 updated by: Peking University Third Hospital
Real Time Early Warning Model and Mobile Medical Assistant System for the Impact of Air Pollution on Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Objective to establish a real-time early warning model of acute exacerbation of chronic obstructive pulmonary disease (COPD) caused by air pollution, and develop the corresponding mobile medical assistant system.
Through the cross fusion of existing information technology and medical research results, an auxiliary medical system is formed for information recording, tracking tools, early warning model and clinical diagnosis of patients with COPD.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Objective to establish a real-time early warning model of acute exacerbation of chronic obstructive pulmonary disease (COPD) caused by air pollution, and develop the corresponding mobile medical assistant system.
Through the cross fusion of existing information technology and medical research results, an auxiliary medical system is formed for information recording, tracking tools, early warning model and clinical diagnosis of patients with COPD.
Study Type
Observational
Enrollment (Actual)
56
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
38 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Stable chronic obstructive pulmonary disease (COPD) patients
Description
Inclusion Criteria:
- Patients aged > 40 and < 80 years with post-bronchodilator FEV1/ forced vital capacity (FVC) < 0.7 and percentage predicted of FEV1>30%, who were no exacerbation of symptoms in the 6 weeks preceding the study, were included in the study.
Exclusion Criteria:
- Patients who were diagnosed with other chronic respiratory diseases, including bronchial asthma, bronchiectasis and lung abscess.
- Patients with near-terminal illness, congestive heart failure (NYHA III-IV), or cannot record CAT score timely were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Low air pollution
|
Types and exposure of different air pollutants in COPD patients' living and working environment
|
High air pollution
|
Types and exposure of different air pollutants in COPD patients' living and working environment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of acute exacerbations
Time Frame: 1 year incidence rate
|
Frequency of acute exacerbations
|
1 year incidence rate
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Yahong Chen, Dr., Peking University Third Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
April 23, 2017
Study Completion (Actual)
December 30, 2018
Study Registration Dates
First Submitted
July 4, 2021
First Submitted That Met QC Criteria
July 4, 2021
First Posted (Actual)
July 13, 2021
Study Record Updates
Last Update Posted (Actual)
July 13, 2021
Last Update Submitted That Met QC Criteria
July 4, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- LM2018072
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Verona Pharma plcMidwest Chest ConsultantsRecruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
University Hospital, BrestRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Baylor Research InstituteNot yet recruiting
Clinical Trials on Types and exposure of different air pollutants
-
Maastricht UniversityWageningen UniversityCompleted
-
National Taiwan University HospitalRecruitingPleural DiseasesTaiwan
-
National Taiwan University HospitalActive, not recruiting
-
Wenzhou Medical UniversityRecruiting
-
Yangzhou UniversityCompletedCalcaneus Fracture
-
Yeditepe UniversityRecruitingCybersicknessTurkey
-
Hospices Civils de LyonRecruitingPersistent Vegetative StateFrance
-
University Hospital, Strasbourg, FranceWithdrawnAllergic Asthma | Allergy to House Dust MiteFrance
-
Children's Hospital of Fudan UniversitySchool of Public Health,Fudan University; Minhang Maternal and Children Health...Active, not recruitingAtopic DermatitisChina
-
The Second Affiliated Hospital of Chongqing Medical...Active, not recruitingAutoimmune Liver Disease, COVID-19China